Physician profile
Rizwan Romee
NPI 1942493101
$30,853.12
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,314 · 2022: $11K · 2023: $100 · 2024: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,920 · Food and Beverage: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,209.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,920.00 |
| Food and Beverage | $379.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| F. Hoffmann-La Roche Ag | $11,489.30 | 2024 | |
| Emd Serono, INC. | $6,120.00 | 2022 | |
| Servier Pharmaceuticals LLC | $4,760.00 | 2022 | |
| Genzyme Corporation | $4,314.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $3,920.00 | 2024 | |
| Genentech, INC. | $149.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $100.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rizwan Romee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.